Patent: 7,012,135
Summary for Patent: 7,012,135
| Title: | Biological products |
| Abstract: | There is disclosed antibody molecules containing at least one CDR derived from a mouse monoclonal antibody having specificity for human TNFα. There is also disclosed a CDR grafted antibody wherein at least one of the CDRs is a hybrid CDR. Further disclosed are DNA sequences encoding the chains of the antibody molecules, vectors, transformed host cells and uses of the antibody molecules in the treatment of diseases mediated by TNFα. |
| Inventor(s): | Diljeet Singh Athwal, Derek Thomas Brown, Andrew Neil Charles Weir, Andrew George Popplewell, Andrew Paul Chapman, David John King |
| Assignee: | UCB SA , Celltech R&D Ltd |
| Application Number: | US09/875,221 |
| Patent Claims: | see list of patent claims |
Details for Patent 7,012,135
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Ucb, Inc. | CIMZIA | certolizumab pegol | For Injection | 125160 | April 22, 2008 | 7,012,135 | 2021-06-06 |
| Ucb, Inc. | CIMZIA | certolizumab pegol | Injection | 125160 | March 28, 2019 | 7,012,135 | 2021-06-06 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
